PARENTERAL DRUGS (INDIA) LTD.

NSE : PDPLBSE : 524689ISIN CODE : INE904D01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.390 (0 %)
PREV CLOSE ( ) 3.39
OPEN PRICE ( ) 3.08
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1250
TODAY'S LOW / HIGH ( )3.08 3.39
52 WK LOW / HIGH ( )3.08 4.14
NSE2.900 (0 %)
PREV CLOSE( ) 2.90
OPEN PRICE ( ) 2.70
BID PRICE (QTY) 2.90 (1373)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1063
TODAY'S LOW / HIGH( ) 2.70 2.90
52 WK LOW / HIGH ( )2.7 3.4
( in Million)
Select year
ParticularsMar2021Mar2020Mar2019Mar2018Mar2017
Profit Before Tax-1544.72-1417.36-1813.98-1412.50-1273.87
Adjustment1437.481278.811647.021218.181095.06
Changes In working Capital1360.461262.194727.551863.841522.01
Cash Flow after changes in Working Capital1253.221123.634560.591669.531343.20
Cash Flow from Operating Activities1253.221123.634770.351669.531344.05
Cash Flow from Investing Activities0.620.79965.77-6.18-5.35
Cash Flow from Financing Activities-1254.35-1124.29-5735.92-1666.19-1343.52
Net Cash Inflow / Outflow-0.510.130.19-2.84-4.82
Opening Cash & Cash Equivalents1.080.950.763.618.43
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent0.571.080.950.763.61

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.